Novo Nordisk A/S Price Today
Novo Nordisk A/S
NVO
Healthcare
$568.72B
💰
Market Cap
47.2
💸
Price to Earnings
$2.7
🎉
EPS
+0
🌳
ESG
Consensus Recommendations
Buy Consensus
Buy |
14 |
Strong Buy |
6 |
Hold |
10 |
Sell |
0 |
Strong Sell |
1 |
NVO Price Forecast Target
127.5 👉 160.0 +26%
NVO EPS Forecast
2.7 👉 4.0 +47%
Financials
Profit Margin
36 %
Revenue Growth
37.0 %
Dividend
$ 1.37
Held Percent
0.0% - Insiders
9.3% - Institutions
90.7% - Public
Major Fund Holders
-
💰 $
-
💰 $
-
💰 $
-
💰 $
-
💰 $
Stock Ideas
Paul Tudor Jones Portfolio
Paul Tudor Jones is a pioneer in macro trading and founder of Tudor Investment Corporation, one of the earliest pioneering hedge funds. With over 40 years of experience investing across global markets, Jones strategically allocates capital based on …
Daniel Loeb Portfolio
Daniel Loeb is an American billionaire businessman and founder/CEO of Third Point LLC, a global investment firm managing over $12 billion in assets through long/short equity investments and activism. As one of the world's most successful hedge fund…
Ron Baron Portfolio
Ron Baron is an American billionaire investor, entrepreneur, and the founder of Baron Capital Group, a well-known investment management firm. He is recognized for his long-term, growth-oriented investment approach and has built a successful track re…
Ken Griffin Portfolio
Ken Griffin, the visionary founder of Citadel Investment Group, has transformed portfolio strategy with his innovative and tech-driven approach. Starting as a college student trading stock options, Griffin quickly rose to success and attracted signi…📮FAQ
Some Frequently Asked Questions.
The Novo Nordisk A/S industry is Biotechnology
The Novo Nordisk A/S sector is Healthcare
The Novo Nordisk A/S forecasted predicted Price to Earnings PE ratio is 32.1
The Novo Nordisk A/S Price to Earnings PE ratio is 47.2
The Market Capitalization of Novo Nordisk A/S is $568.72B
There are total of 3192981244 float shares with 9.3% held by Institutions and 0.0% held by insiders
The MNovo Nordisk A/S forecasted Earnings per Share EPS is $4.0
The Novo Nordisk A/S Earnings per Share EPS is 2.7
The Novo Nordisk A/S company has $0 gross profits with 36 profit margins
The Novo Nordisk A/S Earnings Growth is 0.631% with 0.616% quarterly earnings growth
The Novo Nordisk A/S Revenue is $232260993024 with 0.37 revenue growth
The price target for Novo Nordisk A/S stock is $160.0 for the high target and $130.0 for the low target
The consensus analyst recommendations for Novo Nordisk A/S is Buy, however the decision to buy or sell the stock should be entirely yours, as you are earning your own money and hence responsible on how to allocate and spend them.
The consensus analyst recommendations for Novo Nordisk A/S is Buy, with the following breakdown:
- Buy: 14
- Strong Buy: 6
- Hold: 10
- Sell: 0
- Strong Sell: 1
The Beta of Novo Nordisk A/S is 0.2
The dividend of Novo Nordisk A/S is $1.37
The dividend yield of Novo Nordisk A/S is 0.0108%
The biggest institutional and mutual fund holders of Novo Nordisk A/S stock are
The Novo Nordisk A/S ESG Score is 0, with the following breakdown:
- E: 0
- S: 0
- G: 0